NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Apricot Capital

Apricot Capital

Shanghaiapricot-capital.com

Overview

Apricot Capital is a venture capital firm founded in 2015 that specializes in incubating and scaling early- and growth-stage companies in the biotech, medtech, and life science sectors within China's healthcare ecosystem.

Year Founded

2015

Portfolio Companies

33

Investments

Apricot Capital investments
CompanyDateStageLead
Vivacta Biotechnology (Shanghai) Co., Ltd.Apr 2026Series ACo-investor
Vivatides TherapeuticsApr 2026Series ACo-investor
Vivatides TherapeuticsApr 2026Series ACo-investor
Vivatides TherapeuticsApr 2026Series ACo-investor
Excalipoint TherapeuticsMar 2026SeedCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.